EZH2-IN-7, a potent inhibitor of EZH2, addresses overexpression or mutations in the SET region (Y641F, Y641N, A687V, A677G point mutations) that cause an abnormal increase in H3K27me3, contributing to the proliferation of various tumors, including breast cancer, prostate cancer, and leukemia. It shows promise for cancer research applications.
Molekulargewicht:
563.75
CAS Nummer:
[2659225-28-0]
Formel:
C31H37D2N5O3S
Target-Kategorie:
Histone Methyltransferase
T73246
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
